Code intelligence
Policy changes, MAC LCD updates, and CMS guidance matched to code J3315.
Signal breakdown
3 shown · 3 total in platform
Critical
0%
High
33%
Routine
67%
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Policy FDA-NDA020715 · Oncology
New FDA drug approval. Coverage and billing pathway depend on the FDA label and applicable Medicare LCDs/NCDs — for very recent approvals the label may not be posted yet. Verify against the FDA label and current coverage policy before billing.
Policy FDA-NDA022437 · Oncology
New FDA drug approval. Coverage and billing pathway depend on the FDA label and applicable Medicare LCDs/NCDs — for very recent approvals the label may not be posted yet. Verify against the FDA label and current coverage policy before billing.
Policy FDA-NDA021288 · Oncology
New FDA drug approval. Coverage and billing pathway depend on the FDA label and applicable Medicare LCDs/NCDs — for very recent approvals the label may not be posted yet. Verify against the FDA label and current coverage policy before billing.
Audit documentation
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
